// App-Quantinova.ai

1015 : Pharmacological Induction of NOXA Sensitizes High-Risk B Cell Acute Lymphoblastic Leukemia Cells to Venetoclax

Researchers

Presenter

  • Klaudyna Fidyt

Principal Investigators

  • Julia Cyran

  • Agata Pastorczak

  • Nicholas T. Crump

  • Angelika Muchowicz

  • Agnieszka Goral

  • Krzysztof Domka

  • Lukasz Komorowski

  • Karolina Siudakowska

  • Agnieszka Graczyk-Jarzynka

  • Elzbieta Patkowska

  • Magdalena Winiarska

  • Jakub Golab

  • Thomas A. Milne

  • Malgorzata Firczuk

Medical Centers

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

  • Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland

  • Department of Pediatric Oncology and Hematology Medical University of Bialystok, Bialystok, Poland

  • MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre Haematology Theme, Radcliffe Department of Medicine, University of Oxford,Oxford,United Kingdom

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

Locations

  • Poland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved